ERIGERON CANADENSIS GOUTTE 4CH-30CH DIN 00691127
Health Canada record
| Active ingredient(s) | ERIGERON CANADENSIS L. 1 DH |
|---|---|
| Dosage form | Drops |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1987 |
| Current status date | 09-Feb-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ERIGERON CANADENSIS L.
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02233121 | COMMON MALLOW COMBINATION | SEROYAL INTERNATIONAL INC. | Granules; Globules; Powder; Drops; Capsule; Tablet; Pellet; Liquid | ERIGERON CANADENSIS L. 1 X; SARSAPARILLA 1 X; GOLDENROD 1 X; TARAXACUM OFFICINALE WEBER 1 X; URTICA DIOICA 1 X; BURDOCK 1 X; MALLOW 1 X | Cancelled Post Market |
| 02234465 | ERIGERON CANADENSIS | DOLISOS CANADA INC. | Liquid; Granules; Globules | ERIGERON CANADENSIS L. 1 X | Cancelled Post Market |
| 02080931 | HOMEOPATHIC MEDICINE (S#701) DPS 30C | TOTAL HEALTH CENTRE | Drops | ERIGERON CANADENSIS L. 30 C | Cancelled Post Market |